{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:55:55Z","timestamp":1793501755020,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1038\/nrneurol.2009.26","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T07:57:50Z","timestamp":1239004670000},"page":"222-234","source":"Crossref","is-referenced-by-count":227,"title":["Diagnosis and treatment of Friedreich ataxia: a European perspective"],"prefix":"10.1038","volume":"5","author":[{"given":"J\u00f6rg B.","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Boesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"B\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"D\u00fcrr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Giunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Pousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Sch\u00f6ls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vankan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Pandolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrneurol200926_CR1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano, V. et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423\u20131427 (1996).","journal-title":"Science"},{"key":"BFnrneurol200926_CR2","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1212\/WNL.54.12.2322","volume":"54","author":"M Labuda","year":"2000","unstructured":"Labuda, M. et al. Unique origin and specific ethnic distribution of the Friedreich ataxia GAA expansion. Neurology 54, 2322\u20132324 (2000).","journal-title":"Neurology"},{"key":"BFnrneurol200926_CR3","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1073\/pnas.94.14.7452","volume":"94","author":"M Cossee","year":"1997","unstructured":"Cossee, M. et al. Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proc. Natl Acad. Sci. USA 94, 7452\u20137457 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol200926_CR4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s004390050458","volume":"99","author":"C Epplen","year":"1997","unstructured":"Epplen, C. et al. Differential stability of the (GAA) tract in the Friedreich ataxia (STM7) gene. Hum. Genet. 99, 834\u2013836 (1997).","journal-title":"Hum. Genet."},{"key":"BFnrneurol200926_CR5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00439-001-0642-x","volume":"110","author":"V Juvonen","year":"2002","unstructured":"Juvonen, V. et al. Dissecting the epidemiology of a trinucleotide repeat disease\u2014example of FRDA in Finland. Hum. Genet. 110, 36\u201340 (2002).","journal-title":"Hum. Genet."},{"key":"BFnrneurol200926_CR6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/brain\/114.2.855","volume":"114","author":"JM Polo","year":"1991","unstructured":"Polo, J. M. et al. Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. Brain 114, 855\u2013866 (1991).","journal-title":"Brain"},{"key":"BFnrneurol200926_CR7","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/00001756-200007140-00004","volume":"11","author":"P Wintermeyer","year":"2000","unstructured":"Wintermeyer, P. et al. Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. NeuroReport 11, 2079\u20132082 (2000).","journal-title":"NeuroReport"},{"key":"BFnrneurol200926_CR8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000110795","volume":"9","author":"L Werdelin","year":"1990","unstructured":"Werdelin, L. & Keiding, N. Hereditary ataxias: epidemiological aspects. Neuroepidemiology 9, 321\u2013331 (1990).","journal-title":"Neuroepidemiology"},{"key":"BFnrneurol200926_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1399-0004.1975.tb00331.x","volume":"7","author":"H Skre","year":"1975","unstructured":"Skre, H. Friedreich's ataxia in western Norway. Clin. Genet. 7, 287\u2013298 (1975).","journal-title":"Clin. Genet."},{"key":"BFnrneurol200926_CR10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/sj.ejhg.5200557","volume":"8","author":"J Jonasson","year":"2000","unstructured":"Jonasson, J. et al. Evidence for a common spinocerebellar ataxia type 7 (SCA7) founder mutation in Scandinavia. Eur. J. Hum. Genet. 8, 918\u2013922 (2000).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrneurol200926_CR11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s004390000261","volume":"106","author":"R Colombo","year":"2000","unstructured":"Colombo, R. & Carobene, A. Age of the intronic GAA triplet repeat expansion mutation in Friedreich ataxia. Hum. Genet. 106, 455\u2013458 (2000).","journal-title":"Hum. Genet."},{"key":"BFnrneurol200926_CR12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0002-9297(07)62954-1","volume":"67","author":"M Richards","year":"2000","unstructured":"Richards, M. et al. Tracing European founder lineages in the near Eastern mtDNA pool. Am. J. Hum. Genet. 67, 1251\u20131276 (2000).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol200926_CR13","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1126\/science.290.5494.1155","volume":"290","author":"O Semino","year":"2000","unstructured":"Semino, O. et al. The genetic legacy of Paleolithic Homo sapiens sapiens in extant Europeans: a Y chromosome perspective. Science 290, 1155\u20131159 (2000).","journal-title":"Science"},{"key":"BFnrneurol200926_CR14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1086\/383203","volume":"74","author":"K Tambets","year":"2004","unstructured":"Tambets, K. et al. The western and eastern roots of the Saami\u2014the story of genetic \u201coutliers\u201d told by mitochondrial DNA and Y chromosomes. Am. J. Hum. Genet. 74, 661\u2013682 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol200926_CR15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/hmg\/6.8.1261","volume":"6","author":"L Montermini","year":"1997","unstructured":"Montermini, L. et al. The Friedreich ataxia GAA triplet repeat: premutation and normal alleles. Hum. Mol. Genet. 6, 1261\u20131266 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol200926_CR16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","volume":"104","author":"AE Harding","year":"1981","unstructured":"Harding, A. E. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104, 589\u2013620 (1981).","journal-title":"Brain"},{"key":"BFnrneurol200926_CR17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/brain\/awm323","volume":"131","author":"MC Fahey","year":"2008","unstructured":"Fahey, M. C. et al. Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia. Brain 131, 1035\u20131045 (2008).","journal-title":"Brain"},{"key":"BFnrneurol200926_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00041327-200020040-00002","volume":"20","author":"SJ Givre","year":"2000","unstructured":"Givre, S. J. et al. Visual loss and recovery in a patient with Friedreich ataxia. J. Neuroophthalmol. 20, 229\u2013233 (2000).","journal-title":"J. Neuroophthalmol."},{"key":"BFnrneurol200926_CR19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/jnnp.47.1.26","volume":"47","author":"J Ell","year":"1984","unstructured":"Ell, J. et al. Neuro-otological abnormalities in Friedreich's ataxia. J. Neurol. Neurosurg. Psychiatry 47, 26\u201332 (1984).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200926_CR20","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/brain\/awn104","volume":"131","author":"G Rance","year":"2008","unstructured":"Rance, G. et al. Speech perception ability in individuals with Friedreich ataxia. Brain 131, 2002\u20132012 (2008).","journal-title":"Brain"},{"key":"BFnrneurol200926_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","volume":"145","author":"P Trouillas","year":"1997","unstructured":"Trouillas, P. et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J. Neurol. Sci. 145, 205\u2013211 (1997).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol200926_CR22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.WNL.0000156802.15466.79","volume":"64","author":"SH Subramony","year":"2005","unstructured":"Subramony, S. H. et al. Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology 64, 1261\u20131262 (2005).","journal-title":"Neurology"},{"key":"BFnrneurol200926_CR23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/jnnp.2006.096008","volume":"78","author":"MC Fahey","year":"2007","unstructured":"Fahey, M. C. et al. How is disease progress in Friedreich's ataxia best measured? A study of four rating scales. J. Neurol. Neurosurg. Psychiatry 78, 411\u2013413 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200926_CR24","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch, T. et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66, 1717\u20131720 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol200926_CR25","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/01.wnl.0000218155.46739.90","volume":"66","author":"DR Lynch","year":"2006","unstructured":"Lynch, D. R. et al. Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology 66, 1711\u20131716 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol200926_CR26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","volume":"335","author":"A D\u00fcrr","year":"1996","unstructured":"D\u00fcrr, A. et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Engl. J. Med. 335, 1169\u20131175 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol200926_CR27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ana.410410518","volume":"41","author":"L Montermini","year":"1997","unstructured":"Montermini, L. et al. Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann. Neurol. 41, 675\u2013682 (1997).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol200926_CR28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1600-0404.1988.tb05946.x","volume":"77","author":"A Ulku","year":"1988","unstructured":"Ulku, A. et al. Friedreich's ataxia: a clinical review of 20 childhood cases. Acta Neurol. Scand. 77, 493\u2013497 (1988).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol200926_CR29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-2007-973463","volume":"30","author":"M Alikasifoglu","year":"1999","unstructured":"Alikasifoglu, M. et al. Clinical and genetic correlate in childhood onset Friedreich ataxia. Neuropediatrics 30, 72\u201376 (1999).","journal-title":"Neuropediatrics"},{"key":"BFnrneurol200926_CR30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s004150050362","volume":"246","author":"G Coppola","year":"1999","unstructured":"Coppola, G. et al. Why do some Friedreich's ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study. J. Neurol. 246, 353\u2013357 (1999).","journal-title":"J. Neurol."},{"key":"BFnrneurol200926_CR31","first-page":"485","volume":"46","author":"T Hirai","year":"2006","unstructured":"Hirai, T. et al. Neurological findings, neurophysiological examinations, and sural nerve biopsy in a case of Friedreich ataxia [Japanese]. Rinsho Shinkeigaku 46, 485\u2013490 (2006).","journal-title":"Rinsho Shinkeigaku"},{"key":"BFnrneurol200926_CR32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jnnp.66.1.93","volume":"66","author":"L Santoro","year":"1999","unstructured":"Santoro, L. et al. Relation between trinucleotide GAA repeat length and sensory neuropathy in Friedreich's ataxia. J. Neurol. Neurosurg. Psychiatry 66, 93\u201396 (1999).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200926_CR33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00179990","volume":"71","author":"W Muller-Felber","year":"1993","unstructured":"Muller-Felber, W. et al. The clinical spectrum of Friedreich's ataxia in German families showing linkage to the FRDA locus on chromosome 9. Clin. Invest. 71, 109\u2013114 (1993).","journal-title":"Clin. Invest."},{"key":"BFnrneurol200926_CR34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.33588\/rn.4404.2006072","volume":"44","author":"S Santiago-Perez","year":"2007","unstructured":"Santiago-Perez, S. et al. A neurophysiological study of the alterations to the central and peripheral nervous systems in Friedreich's ataxia [Spanish]. Rev. Neurol. 44, 193\u2013197 (2007).","journal-title":"Rev. Neurol."},{"key":"BFnrneurol200926_CR35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1388-2457(00)00290-X","volume":"111","author":"L Santoro","year":"2000","unstructured":"Santoro, L. et al. Influence of GAA expansion size and disease duration on central nervous system impairment in Friedreich's ataxia: contribution to the understanding of the pathophysiology of the disease. Clin. Neurophysiol. 111, 1023\u20131030 (2000).","journal-title":"Clin. Neurophysiol."},{"key":"BFnrneurol200926_CR36","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/jnnp.51.6.790","volume":"51","author":"D Claus","year":"1988","unstructured":"Claus, D. et al. Central motor conduction in degenerative ataxic disorders: a magnetic stimulation study. J. Neurol. Neurosurg. Psychiatry 51, 790\u2013795 (1988).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200926_CR37","first-page":"415","volume":"35","author":"M Mondelli","year":"1995","unstructured":"Mondelli, M. et al. Motor evoked potentials by magnetic stimulation in hereditary and sporadic ataxia. Electromyogr. Clin. Neurophysiol. 35, 415\u2013424 (1995).","journal-title":"Electromyogr. Clin. Neurophysiol."},{"key":"BFnrneurol200926_CR38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0165-5876(03)00036-3","volume":"67","author":"E Lopez-Diaz-de-Leon","year":"2003","unstructured":"Lopez-Diaz-de-Leon, E. et al. Auditory neuropathy in Friedreich ataxia. A report of two cases. Int. J. Pediatr. Otorhinolaryngol. 67, 641\u2013648 (2003).","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"BFnrneurol200926_CR39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2214\/ajr.163.1.8010211","volume":"163","author":"M Mascalchi","year":"1994","unstructured":"Mascalchi, M. et al. Friedreich's ataxia: MR findings involving the cervical portion of the spinal cord. AJR Am. J. Roentgenol. 163, 187\u2013191 (1994).","journal-title":"AJR Am. J. Roentgenol."},{"key":"BFnrneurol200926_CR40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/jnnp.2007.124297","volume":"79","author":"R Della Nave","year":"2008","unstructured":"Della Nave, R. et al. Brain structural damage in Friedreich's ataxia. J. Neurol. Neurosurg. Psychiatry 79, 82\u201385 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200926_CR41","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0002-9149(97)89194-1","volume":"77","author":"F Casazza","year":"1996","unstructured":"Casazza, F. & Morpurgo, M. The varying evolution of Friedreich's ataxia cardiomyopathy. Am. J. Cardiol. 77, 895\u2013898 (1996).","journal-title":"Am. J. Cardiol."},{"key":"BFnrneurol200926_CR42","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/mds.21590","volume":"22","author":"C Meyer","year":"2007","unstructured":"Meyer, C. et al. Cardiomyopathy in Friedreich's ataxia\u2014assessment by cardiac MRI. Mov. Disord. 22, 1615\u20131622 (2007).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200926_CR43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1253\/jcj.64.229","volume":"64","author":"C Kawai","year":"2000","unstructured":"Kawai, C. et al. Heart disease in Friedreich's ataxia: observation of a case for half a century. Jpn. Circ. J. 64, 229\u2013236 (2000).","journal-title":"Jpn. Circ. J."},{"key":"BFnrneurol200926_CR44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1017\/S0317167100022915","volume":"7","author":"P Allard","year":"1980","unstructured":"Allard, P. et al. Pathomechanics and management of scoliosis in Friedreich ataxia patients: preliminary report. Can. J. Neurol. Sci. 7, 383\u2013388 (1980).","journal-title":"Can. J. Neurol. Sci."},{"key":"BFnrneurol200926_CR45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01241398-198411000-00003","volume":"4","author":"RB Cady","year":"1984","unstructured":"Cady, R. B. & Bobechko, W. P. Incidence, natural history, and treatment of scoliosis in Friedreich's ataxia. J. Pediatr. Orthop. 4, 673\u2013676 (1984).","journal-title":"J. Pediatr. Orthop."},{"key":"BFnrneurol200926_CR46","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2106\/00004623-198668040-00013","volume":"68","author":"H Labelle","year":"1986","unstructured":"Labelle, H. et al. Natural history of scoliosis in Friedreich's ataxia. J. Bone Joint Surg. Am. 68, 564\u2013572 (1986).","journal-title":"J. Bone Joint Surg. Am."},{"key":"BFnrneurol200926_CR47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/BPO.0b013e318164fa79","volume":"28","author":"TA Milbrandt","year":"2008","unstructured":"Milbrandt, T. A. et al. Friedreich's ataxia and scoliosis: the experience at two institutions. J. Pediatr. Orthop. 28, 234\u2013238 (2008).","journal-title":"J. Pediatr. Orthop."},{"key":"BFnrneurol200926_CR48","first-page":"270","volume":"311","author":"M Beauchamp","year":"1995","unstructured":"Beauchamp, M. et al. Natural history of muscle weakness in Friedreich's ataxia and its relation to loss of ambulation. Clin. Orthop. Relat. Res. 311, 270\u2013275 (1995).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"BFnrneurol200926_CR49","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1212\/WNL.51.6.1666","volume":"51","author":"ML Moseley","year":"1998","unstructured":"Moseley, M. L. et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 51, 1666\u20131671 (1998).","journal-title":"Neurology"},{"key":"BFnrneurol200926_CR50","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0959-437X(02)00298-8","volume":"12","author":"H Puccio","year":"2002","unstructured":"Puccio, H. & Koenig, M. Friedreich ataxia: a paradigm for mitochondrial diseases. Curr. Opin. Genet. Dev. 12, 272\u2013277 (2002).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnrneurol200926_CR51","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.1001","volume":"49","author":"R Lodi","year":"2001","unstructured":"Lodi, R. et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann. Neurol. 49, 590\u2013596 (2001).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol200926_CR52","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archneur.62.4.621","volume":"62","author":"PE Hart","year":"2005","unstructured":"Hart, P. E. et al. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch. Neurol. 62, 621\u2013626 (2005).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200926_CR53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(99)01341-0","volume":"354","author":"P Rustin","year":"1999","unstructured":"Rustin, P. et al. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 354, 477\u2013479 (1999).","journal-title":"Lancet"},{"key":"BFnrneurol200926_CR54","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/heart.87.4.346","volume":"87","author":"AO Hausse","year":"2002","unstructured":"Hausse, A. O. et al. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia. Heart 87, 346\u2013349 (2002).","journal-title":"Heart"},{"key":"BFnrneurol200926_CR55","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1212\/01.WNL.0000068549.52812.0F","volume":"60","author":"G Buyse","year":"2003","unstructured":"Buyse, G. et al. Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring. Neurology 60, 1679\u20131681 (2003).","journal-title":"Neurology"},{"key":"BFnrneurol200926_CR56","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1212\/01.WNL.0000055872.50364.FC","volume":"60","author":"C Mariotti","year":"2003","unstructured":"Mariotti, C. et al. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurology 60, 1676\u20131679 (2003).","journal-title":"Neurology"},{"key":"BFnrneurol200926_CR57","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archneur.64.4.558","volume":"64","author":"P Ribai","year":"2007","unstructured":"Ribai, P. et al. Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up. Arch. Neurol. 64, 558\u2013564 (2007).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200926_CR58","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejpn.2007.11.006","volume":"12","author":"M Pineda","year":"2008","unstructured":"Pineda, M. et al. Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up. Eur. J. Paediatr. Neurol. 12, 470\u2013475 (2008).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"BFnrneurol200926_CR59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(01)01892-4","volume":"306","author":"L Sch\u00f6ls","year":"2001","unstructured":"Sch\u00f6ls, L. et al. Idebenone in patients with Friedreich ataxia. Neurosci. Lett. 306, 169\u2013172 (2001).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol200926_CR60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4414\/sanp.2006.01730","volume":"157","author":"P Arnold","year":"2006","unstructured":"Arnold, P. et al. Expanding view of phenotype and oxidative stress in Friedreich's ataxia patients with and without idebenone. Schweiz. Arch. Neurol. Psychiatr. 157, 169\u2013175 (2006).","journal-title":"Schweiz. Arch. Neurol. Psychiatr."},{"key":"BFnrneurol200926_CR61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2002-34494","volume":"33","author":"R Artuch","year":"2002","unstructured":"Artuch, R. et al. Friedreich's ataxia: idebenone treatment in early stage patients. Neuropediatrics 33, 190\u2013193 (2002).","journal-title":"Neuropediatrics"},{"key":"BFnrneurol200926_CR62","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/10715760290021333","volume":"36","author":"P Rustin","year":"2002","unstructured":"Rustin, P. et al. Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia. Free Radic. Res. 36, 467\u2013469 (2002).","journal-title":"Free Radic. Res."},{"key":"BFnrneurol200926_CR63","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archneur.64.6.803","volume":"64","author":"NA Di Prospero","year":"2007","unstructured":"Di Prospero, N. A. et al. Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia. Arch. Neurol. 64, 803\u2013808 (2007).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200926_CR64","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","volume":"6","author":"NA Di Prospero","year":"2007","unstructured":"Di Prospero, N. A. et al. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Lancet Neurol. 6, 878\u2013886 (2007).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol200926_CR65","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00702-004-0216-x","volume":"112","author":"L Schols","year":"2005","unstructured":"Schols, L. et al. L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial. J. Neural Transm. 112, 789\u2013796 (2005).","journal-title":"J. Neural Transm."},{"key":"BFnrneurol200926_CR66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00002826-200003000-00010","volume":"23","author":"S Sorbi","year":"2000","unstructured":"Sorbi, S. et al. Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia. Clin. Neuropharmacol. 23, 114\u2013118 (2000).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol200926_CR67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","volume":"142","author":"ER Miller","year":"2005","unstructured":"Miller, E. R. 3rd et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142, 37\u201346 (2005).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneurol200926_CR68","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/hmg\/ddn127","volume":"17","author":"K Li","year":"2008","unstructured":"Li, K. et al. Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia. Hum. Mol. Genet. 17, 2265\u20132273 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol200926_CR69","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2006-12-065433","volume":"110","author":"N Boddaert","year":"2007","unstructured":"Boddaert, N. et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110, 401\u2013408 (2007).","journal-title":"Blood"},{"key":"BFnrneurol200926_CR70","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1182\/blood-2007-07-102335","volume":"111","author":"YS Sohn","year":"2008","unstructured":"Sohn, Y. S. et al. Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. Blood 111, 1690\u20131699 (2008).","journal-title":"Blood"},{"key":"BFnrneurol200926_CR71","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21177","volume":"62","author":"S Boesch","year":"2007","unstructured":"Boesch, S. et al. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin. Ann. Neurol. 62, 521\u2013524 (2007).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol200926_CR72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nchembio815","volume":"2","author":"D Herman","year":"2006","unstructured":"Herman, D. et al. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat. Chem. Biol. 2, 551\u2013558 (2006).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrneurol200926_CR73","doi-asserted-by":"crossref","first-page":"e1958","DOI":"10.1371\/journal.pone.0001958","volume":"3","author":"M Rai","year":"2008","unstructured":"Rai, M. et al. HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS ONE 3, e1958 (2008).","journal-title":"PLoS ONE"},{"key":"BFnrneurol200926_CR74","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2522\/ptj.20060232","volume":"87","author":"JR Maring","year":"2007","unstructured":"Maring, J. R. & Croarkin, E. Presentation and progression of Friedreich ataxia and implications for physical therapist examination. Phys. Ther. 87, 1687\u20131696 (2007).","journal-title":"Phys. Ther."},{"key":"BFnrneurol200926_CR75","unstructured":"American Physical therapy Association. Guide to Physical Therapist Practice, 2nd edn (American Physical Therapy Association, Alexandria, 2001)."},{"key":"BFnrneurol200926_CR76","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.blo.0000150339.74041.0e","volume":"430","author":"MB Delatycki","year":"2005","unstructured":"Delatycki, M. B. et al. Surgery for equinovarus deformity in Friedreich's ataxia improves mobility and independence. Clin. Orthop. Relat. Res. 430, 138\u2013141 (2005).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"BFnrneurol200926_CR77","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/0888439004267241","volume":"18","author":"MO Harris-Love","year":"2004","unstructured":"Harris-Love, M. O. et al. Rehabilitation management of Friedreich ataxia: lower extremity force-control variability and gait performance. Neurorehabil. Neural Repair 18, 117\u2013124 (2004).","journal-title":"Neurorehabil. Neural Repair"},{"key":"BFnrneurol200926_CR78","first-page":"93","volume":"44","author":"C Goulipian","year":"2008","unstructured":"Goulipian, C. et al. Orthopedic shoes improve gait in Friedreich's ataxia: a clinical and quantified case study. Eur. J. Phys. Rehabil. Med. 44, 93\u201398 (2008).","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"BFnrneurol200926_CR79","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/mds.20405","volume":"20","author":"D Ben Smail","year":"2005","unstructured":"Ben Smail, D. et al. Intrathecal baclofen in the treatment of painful, disabling spasms in Friedreich's ataxia. Mov. Disord. 20, 758\u2013759 (2005).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200926_CR80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pediatrneurol.2005.08.010","volume":"34","author":"ES Cardoso","year":"2006","unstructured":"Cardoso, E. S. et al. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy. Pediatr. Neurol. 34, 106\u2013109 (2006).","journal-title":"Pediatr. Neurol."},{"key":"BFnrneurol200926_CR81","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0966-6362(03)00098-5","volume":"20","author":"H Bateni","year":"2004","unstructured":"Bateni, H. et al. Can use of walkers or canes impede lateral compensatory stepping movements? Gait Posture 20, 74\u201383 (2004).","journal-title":"Gait Posture"},{"key":"BFnrneurol200926_CR82","first-page":"786","volume":"70","author":"MJ Fillyaw","year":"1989","unstructured":"Fillyaw, M. J. & Ades, P. A. Endurance exercise training in Friedreich ataxia. Arch. Phys. Med. Rehabil. 70, 786\u2013788 (1989).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"BFnrneurol200926_CR83","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1044\/jshd.5503.550","volume":"55","author":"KM Yorkston","year":"1990","unstructured":"Yorkston, K. M. et al. The effect of rate control on the intelligibility and naturalness of dysarthric speech. J. Speech Hear. Disord. 55, 550\u2013560 (1990).","journal-title":"J. Speech Hear. Disord."},{"key":"BFnrneurol200926_CR84","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1044\/1058-0360(2003\/085)","volume":"12","author":"S Sapir","year":"2003","unstructured":"Sapir, S. et al. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study. Am. J. Speech Lang. Pathol. 12, 387\u2013399 (2003).","journal-title":"Am. J. Speech Lang. Pathol."},{"key":"BFnrneurol200926_CR85","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/jnnp.71.4.493","volume":"71","author":"LO Ramig","year":"2001","unstructured":"Ramig, L. O. et al. Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up. J. Neurol. Neurosurg. Psychiatry 71, 493\u2013498 (2001).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200926_CR86","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1044\/jshd.5502.217","volume":"55","author":"KM Yorkston","year":"1990","unstructured":"Yorkston, K. M. et al. Extended communication samples of augmented communicators. I: A comparison of individualized versus standard single-word vocabularies. J. Speech Hear. Disord. 55, 217\u2013224 (1990).","journal-title":"J. Speech Hear. Disord."},{"key":"BFnrneurol200926_CR87","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-2006-955118","volume":"27","author":"CM Fox","year":"2006","unstructured":"Fox, C. M. et al. The science and practice of LSVT\/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. Semin. Speech Lang. 27, 283\u2013299 (2006).","journal-title":"Semin. Speech Lang."},{"key":"BFnrneurol200926_CR88","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.brainresbull.2006.06.001","volume":"70","author":"LA Corben","year":"2006","unstructured":"Corben, L. A. et al. Towards an understanding of cognitive function in Friedreich ataxia. Brain Res. Bull. 70, 197\u2013202 (2006).","journal-title":"Brain Res. Bull."},{"key":"BFnrneurol200926_CR89","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1034\/j.1600-0404.2000.102004222.x","volume":"102","author":"M White","year":"2000","unstructured":"White, M. et al. Neuropsychologic and neuropsychiatric characteristics of patients with Friedreich's ataxia. Acta Neurol. Scand. 102, 222\u2013226 (2000).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol200926_CR90","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archneur.1995.00540290037015","volume":"52","author":"K Wessel","year":"1995","unstructured":"Wessel, K. et al. Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases. Arch. Neurol. 52, 451\u2013455 (1995).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200926_CR91","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1468-1331.2007.01881.x","volume":"14","author":"CL Wilson","year":"2007","unstructured":"Wilson, C. L. et al. Quality of life in Friedreich ataxia: what clinical, social and demographic factors are important? Eur. J. Neurol. 14, 1040\u20131047 (2007).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol200926_CR92","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/02599148709166219","volume":"9","author":"R D'Ambrosio","year":"1987","unstructured":"D'Ambrosio, R. et al. Disability and quality of life in hereditary ataxias: a self-administered postal questionnaire. Int. Disabil. Stud. 9, 10\u201314 (1987).","journal-title":"Int. Disabil. Stud."},{"key":"BFnrneurol200926_CR93","first-page":"657","volume":"66","author":"K Levent","year":"2000","unstructured":"Levent, K. et al. Anaesthesia for Friedreich's ataxia. Case report. Minerva Anestesiol. 66, 657\u2013660 (2000).","journal-title":"Minerva Anestesiol."},{"key":"BFnrneurol200926_CR94","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/bja\/aeh106","volume":"92","author":"HJ Schmitt","year":"2004","unstructured":"Schmitt, H. J. et al. Rocuronium for muscle relaxation in two children with Friedreich's ataxia. Br. J. Anaesth. 92, 592\u2013596 (2004).","journal-title":"Br. J. Anaesth."},{"key":"BFnrneurol200926_CR95","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2044.2007.05055.x","volume":"62","author":"PC Kam","year":"2007","unstructured":"Kam, P. C. & Cardone, D. Propofol infusion syndrome. Anaesthesia 62, 690\u2013701 (2007).","journal-title":"Anaesthesia"},{"key":"BFnrneurol200926_CR96","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/bean.2002.0266","volume":"17","author":"TG Short","year":"2003","unstructured":"Short, T. G. & Young, Y. Toxicity of intravenous anaesthetics. Best Pract. Res. Clin. Anaesthesiol. 17, 77\u201389 (2003).","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"BFnrneurol200926_CR97","first-page":"976","volume":"76","author":"JP Bruner","year":"1990","unstructured":"Bruner, J. P. & Yeast, J. D. Pregnancy associated with Friedreich ataxia. Obstet. Gynecol. 76, 976\u2013977 (1990).","journal-title":"Obstet. Gynecol."},{"key":"BFnrneurol200926_CR98","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1474-4422(07)70054-6","volume":"6","author":"BL Fogel","year":"2007","unstructured":"Fogel, B. L. & Perlman, S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol. 6, 245\u2013257 (2007).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol200926_CR99","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1034\/j.1600-0404.2000.102004227.x","volume":"102","author":"M Mukerji","year":"2000","unstructured":"Mukerji, M. et al. Molecular analysis of Friedreich's ataxia locus in the Indian population. Acta Neurol. Scand. 102, 227\u2013229 (2000).","journal-title":"Acta Neurol. Scand."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2009.26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2009.26","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2009.26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T21:21:02Z","timestamp":1739049662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2009.26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["BFnrneurol200926"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2009.26","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}